US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6726930B1
(en)
*
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US5612053A
(en)
*
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
US6540993B1
(en)
*
|
1995-06-27 |
2003-04-01 |
Wyeth |
Method of treating inflammatory bowel disease using a topical formulation of IL-11
|
AU2068797A
(en)
*
|
1996-01-29 |
1997-08-20 |
Edward Mendell Co. Inc. |
Sustained release excipient
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5855913A
(en)
*
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
USRE37053E1
(en)
|
1996-05-24 |
2001-02-13 |
Massachusetts Institute Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US6503480B1
(en)
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US5846568A
(en)
*
|
1996-09-19 |
1998-12-08 |
Xyrofin Oy |
Directly compressible lactitol and method
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
EP0876814A1
(en)
*
|
1997-05-07 |
1998-11-11 |
"PHARLYSE", Société Anonyme |
Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
IN186245B
(en)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US6433040B1
(en)
*
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
JP3005657B2
(en)
*
|
1997-11-19 |
2000-01-31 |
彰 堀金 |
Lyophilization method, apparatus and lyophilizate
|
US7022683B1
(en)
*
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
US6956021B1
(en)
*
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
US6599883B1
(en)
|
1998-10-30 |
2003-07-29 |
Nastech Pharmaceutical Company, Inc. |
Nasal delivery of xylitol
|
ATE424810T1
(en)
|
1998-12-11 |
2009-03-15 |
Nostrum Pharmaceuticals Inc |
A DELAYED-RELEASE TABLET CONTAINING A HYDROCOLLOID AND A CELLULOSE ETHER
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
CA2382821A1
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US6376242B1
(en)
*
|
1999-09-21 |
2002-04-23 |
Emory University |
Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents
|
IL143375A0
(en)
*
|
1999-09-30 |
2002-04-21 |
Penwest Pharmaceuticals Co |
Sustained release matrix systems for highly soluble drugs
|
WO2001056581A1
(en)
*
|
2000-02-04 |
2001-08-09 |
Kissei Pharmaceutical Co., Ltd. |
Powdered preparation for inhalation and powder inhalant containing the same packed
|
GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
GB0009468D0
(en)
*
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
WO2001085136A2
(en)
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
DK1913939T3
(en)
|
2000-06-27 |
2017-09-18 |
Vectura Ltd |
Formulations for use in inhalers
|
US20020106368A1
(en)
*
|
2000-07-28 |
2002-08-08 |
Adrian Bot |
Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
|
CA2423558A1
(en)
*
|
2000-10-03 |
2002-04-11 |
Penwest Pharmaceuticals Company |
Delivery system for multi-pharmaceutical active materials at various release rates
|
DE60140268D1
(en)
*
|
2000-11-30 |
2009-12-03 |
Vectura Ltd |
PARTICLES FOR USE IN A PHARMACEUTICAL COMPOSITION
|
EP3269360A1
(en)
|
2000-11-30 |
2018-01-17 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
CA2433335C
(en)
*
|
2000-12-29 |
2010-04-20 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having sustained release properties
|
US20030125236A1
(en)
*
|
2000-12-29 |
2003-07-03 |
Advenced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
HUP0501071A3
(en)
*
|
2001-03-13 |
2007-06-28 |
Penwest Pharmaceutical Co |
Chronotherapeutic dosage forms
|
GB0107106D0
(en)
*
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
WO2002094216A2
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of stimulants through an inhalation route
|
DE60227659D1
(en)
*
|
2001-05-24 |
2008-08-28 |
Alexza Pharmaceuticals Inc |
ADMINISTRATION OF ANTIHISTAMINICA BY INHALATION
|
DE60228231D1
(en)
*
|
2001-05-24 |
2008-09-25 |
Alexza Pharmaceuticals Inc |
ADMINISTRATION OF ANTI-PARKIN SOLVENTS BY INHALATION
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
US7090830B2
(en)
*
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US6759029B2
(en)
*
|
2001-05-24 |
2004-07-06 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan and zolmitriptan through an inhalation route
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
WO2002094240A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of physiologically active compounds through an inhalation route
|
US7078016B2
(en)
|
2001-11-21 |
2006-07-18 |
Alexza Pharmaceuticals, Inc. |
Delivery of caffeine through an inhalation route
|
US6737043B2
(en)
*
|
2001-05-24 |
2004-05-18 |
Alexza Molecula Delivery Corporation |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
US7766013B2
(en)
*
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
US6737042B2
(en)
*
|
2001-05-24 |
2004-05-18 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
US20070122353A1
(en)
*
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US6805853B2
(en)
*
|
2001-11-09 |
2004-10-19 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
US6482429B1
(en)
*
|
2001-06-20 |
2002-11-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Stable powder inhalation dosage formulation
|
EP1409140B1
(en)
*
|
2001-06-29 |
2005-08-10 |
Eurand Pharmaceuticals Ltd. |
Drug activation process with a vibrational mill
|
US8329216B2
(en)
*
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
DK1404331T3
(en)
*
|
2001-07-06 |
2008-01-28 |
Penwest Pharmaceuticals Co |
Sustained release formulations of oxymorphone
|
CA2452874A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Endo Pharmaceuticals, Inc. |
Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
|
US20030091635A1
(en)
*
|
2001-09-26 |
2003-05-15 |
Baichwal Anand R. |
Opioid formulations having reduced potential for abuse
|
IL160928A0
(en)
*
|
2001-10-19 |
2004-08-31 |
Maxim Pharm Inc |
Use of histamine to treat liver disease
|
US6896894B2
(en)
|
2001-10-30 |
2005-05-24 |
Battelle Memorial Institute |
Proteins stabilized with polysaccharide gums
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
AU2002352836B2
(en)
*
|
2001-11-20 |
2005-09-29 |
Alkermes, Inc. |
Improved particulate compositions for pulmonary delivery
|
JP2005514393A
(en)
*
|
2001-12-19 |
2005-05-19 |
ネクター セラピューティクス |
Supplying aminoglycosides to the lung
|
SE0200657D0
(en)
*
|
2002-03-04 |
2002-03-04 |
Astrazeneca Ab |
Novel Formulation
|
EP1480691A4
(en)
*
|
2002-03-05 |
2007-11-28 |
Univ State Cleveland |
Agglomerated particles for aerosol drug delivery
|
MXPA04009701A
(en)
*
|
2002-04-05 |
2005-05-27 |
Penwest Pharmaceuticals Co |
Sustained release metoprolol formulations.
|
WO2003086358A1
(en)
*
|
2002-04-12 |
2003-10-23 |
Campina Nederland Holding B.V. |
Excipient for use in dry powder inhalation preparations
|
US20030204180A1
(en)
*
|
2002-04-30 |
2003-10-30 |
Kimberly-Clark Worldwide, Inc. |
Temperature responsive delivery systems
|
EP1503744A1
(en)
|
2002-05-13 |
2005-02-09 |
Alexza Molecular Delivery Corporation |
Delivery of drug amines through an inhalation route
|
CA2488976C
(en)
*
|
2002-06-28 |
2009-08-25 |
Advanced Inhalation Research, Inc. |
Inhalable epinephrine
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
WO2004017913A2
(en)
*
|
2002-08-22 |
2004-03-04 |
Nutrition 21, Inc. |
Arginine silicate inositol complex and use thereof
|
CN1717237A
(en)
*
|
2002-11-26 |
2006-01-04 |
艾利斯达分子传输公司 |
Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
|
US20040105818A1
(en)
*
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
US7550133B2
(en)
*
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
NZ540208A
(en)
*
|
2002-11-26 |
2007-09-28 |
Alexza Pharmaceuticals Inc |
Treatment of headache with antipsychotics delivered by inhalation
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
CN1744917B
(en)
*
|
2003-02-26 |
2010-05-05 |
大塚制药株式会社 |
Sustained-release pharmaceutical composition for lung administration
|
ATE520935T1
(en)
|
2003-05-21 |
2011-09-15 |
Alexza Pharmaceuticals Inc |
USE OF A SOLID FUEL LAYER, METHOD FOR PRODUCING SUCH A LAYER AND ASSOCIATED HEATING DEVICE
|
GB0312148D0
(en)
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
US6994726B2
(en)
*
|
2004-05-25 |
2006-02-07 |
Calcitec, Inc. |
Dual function prosthetic bone implant and method for preparing the same
|
NO319624B1
(en)
|
2003-09-15 |
2005-09-05 |
Trouw Internat Bv |
Fish feed for salmonids in fresh water and use of such feed.
|
MXPA06003100A
(en)
*
|
2003-09-19 |
2006-06-20 |
Penwest Pharmaceuticals Co |
Delayed released dosage forms.
|
MXPA06003101A
(en)
*
|
2003-09-19 |
2006-06-20 |
Penwest Pharmaceuticals Co |
Chronotherapeutic dosage forms.
|
US20050171192A1
(en)
*
|
2003-12-11 |
2005-08-04 |
Gehlsen Kurt R. |
Use of histamine to treat bone disease
|
WO2005061088A1
(en)
*
|
2003-12-22 |
2005-07-07 |
Finlay Warren H |
Powder formation by atmospheric spray-freeze drying
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
GB0409703D0
(en)
*
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
WO2006009975A2
(en)
*
|
2004-06-22 |
2006-01-26 |
Maxim Pharmaceuticals, Inc. |
Histamine to treat disorders affecting muscle function
|
CA2568834A1
(en)
*
|
2004-06-29 |
2006-01-12 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising steroids and an anticholinergic
|
US20060004076A1
(en)
*
|
2004-06-30 |
2006-01-05 |
Inflabloc Pharmaceuticals, Inc. |
Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
US20070178165A1
(en)
*
|
2005-12-15 |
2007-08-02 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for parenteral administration
|
WO2007070851A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
JP4907191B2
(en)
*
|
2006-02-17 |
2012-03-28 |
日本発條株式会社 |
Conductive contact unit
|
US20070212414A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
WO2008030557A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Johns Hopkins University |
Compositions and methods for enhancing transport through mucus
|
US9032971B2
(en)
*
|
2006-11-15 |
2015-05-19 |
Philip Morris Usa Inc. |
Moist tobacco product and method of making
|
CA2670636A1
(en)
|
2006-11-27 |
2008-06-05 |
H. Lundbeck A/S |
Heteroaryl amide derivatives
|
WO2008080170A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Alexza Pharmaceuticals, Inc. |
Mixed drug aerosol compositiions
|
WO2008112661A2
(en)
|
2007-03-09 |
2008-09-18 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US20090124650A1
(en)
*
|
2007-06-21 |
2009-05-14 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
|
GB2460915B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
MX2011009956A
(en)
*
|
2009-03-26 |
2012-01-27 |
Pulmatrix Inc |
Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining.
|
EP2410981B2
(en)
|
2009-03-26 |
2020-02-26 |
Pulmatrix Operating Company, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
EP2435023B1
(en)
*
|
2009-05-29 |
2016-07-06 |
Pearl Therapeutics, Inc. |
Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta 2 adrenergic receptor agonists and associated methods and systems
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
AU2011230144B2
(en)
*
|
2010-03-22 |
2015-01-22 |
Bio-Synectics Inc. |
Method for preparing nano-particles
|
US9061352B2
(en)
|
2010-08-30 |
2015-06-23 |
Pulmatrix, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
US8758824B2
(en)
|
2010-08-30 |
2014-06-24 |
Pulmatrix, Inc. |
Respirably dry powder comprising calcium lactate, sodium chloride and leucine
|
PT3470057T
(en)
|
2010-09-29 |
2021-12-03 |
Pulmatrix Operating Co Inc |
Cationic dry powders comprising magnesium salt
|
RU2017144619A
(en)
|
2010-09-29 |
2019-02-20 |
Пулмэтрикс, Инк. |
CASES OF SINGLE-VALVE METALS OF DRY POWDERS FOR INHALATIONS
|
US20150136130A1
(en)
|
2012-02-29 |
2015-05-21 |
Pulmatrix, Inc. |
Inhalable dry powders
|
EP2826479B1
(en)
*
|
2012-03-14 |
2019-02-20 |
LTT Bio-Pharma Co., Ltd. |
Ameliorating agent for chronic obstructive pulmonary disease
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
KR102140989B1
(en)
|
2012-05-03 |
2020-08-04 |
칼라 파마슈티컬스, 인크. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
CA2871745C
(en)
|
2012-05-03 |
2023-01-24 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
AU2014228414B2
(en)
|
2013-03-15 |
2018-09-13 |
Pearl Therapeutics, Inc. |
Methods and systems for conditioning of particulate crystalline materials
|
CA2907566C
(en)
|
2013-04-01 |
2023-08-22 |
Pulmatrix, Inc. |
Tiotropium dry powders
|
US11191735B2
(en)
|
2015-03-13 |
2021-12-07 |
Nutrition 21, Llc |
Arginine silicate for periodontal disease
|
US20170135969A1
(en)
|
2015-11-12 |
2017-05-18 |
Jds Therapeutics, Llc |
Topical arginine-silicate-inositol for wound healing
|
JP2018533596A
(en)
|
2015-11-12 |
2018-11-15 |
グレイバグ ビジョン インコーポレイテッド |
Aggregated microparticles for medical therapy
|
CN109890384A
(en)
|
2016-09-01 |
2019-06-14 |
Jds治疗有限公司 |
Biotin magnesium compositions and application method
|
JP2020519585A
(en)
|
2017-05-10 |
2020-07-02 |
グレイバグ ビジョン インコーポレイテッド |
Extended release microparticles and suspensions thereof for medical therapy
|
US20210361581A1
(en)
*
|
2018-10-22 |
2021-11-25 |
Ioi Oleo Gmbh |
Additive for a powder material intended for compaction into shaped bodies
|
EP3873331A4
(en)
|
2018-11-02 |
2022-08-24 |
Nutrition 21, LLC |
Compositions containing inositol-stabilized arginine silicate complexes and inositol for improving cognitive function in video gamers
|
WO2021127048A1
(en)
|
2019-12-16 |
2021-06-24 |
Nutrition 21, Llc |
Methods of production of arginine-silicate complexes
|